将近两年之后，只有不到13%的服用依普利酮的人死于心脏问题。而相较之下，服用安慰剂的但死于心脏问题的人却逼近16%。

After nearly two years, less than 13 percent of those on Inspra had died of heart problems versus less than 16 percent of those given dummy pills.

youdao

许多医生一经发现了替代依普利酮的药品，而且比依普利酮更早出产，应用面更广。它就是安体舒通。这种药每天只需花费不到20美分。同依普利酮每月大约133美元的用费相比，它实惠很多。

Many doctors saw an alternative: wider use of an older relative of Inspra, spironolactone, a generic medicine that costs less than 20 cents a day, versus about $133 a month for Inspra.

youdao

在对2700多位症状有所缓解的患者进行的研究中发现，依普利酮将死亡或住院治疗的风险降低了37%。

In a study of more than 2,700 people with milder symptoms, it cut the risk of death or hospitalization by 37 percent.

youdao